AU3864089A - Nonglycosylated human interleukin-3 compositions - Google Patents

Nonglycosylated human interleukin-3 compositions

Info

Publication number
AU3864089A
AU3864089A AU38640/89A AU3864089A AU3864089A AU 3864089 A AU3864089 A AU 3864089A AU 38640/89 A AU38640/89 A AU 38640/89A AU 3864089 A AU3864089 A AU 3864089A AU 3864089 A AU3864089 A AU 3864089A
Authority
AU
Australia
Prior art keywords
compositions
human interleukin
nonglycosylated human
nonglycosylated
interleukin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU38640/89A
Inventor
Dirk M. Anderson
David J. Cosman
Virginia L. Price
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunex Corp
Original Assignee
Immunex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunex Corp filed Critical Immunex Corp
Publication of AU3864089A publication Critical patent/AU3864089A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU38640/89A 1988-07-20 1989-06-14 Nonglycosylated human interleukin-3 compositions Abandoned AU3864089A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22169988A 1988-07-20 1988-07-20
US221699 1988-07-20

Publications (1)

Publication Number Publication Date
AU3864089A true AU3864089A (en) 1990-02-19

Family

ID=22828962

Family Applications (1)

Application Number Title Priority Date Filing Date
AU38640/89A Abandoned AU3864089A (en) 1988-07-20 1989-06-14 Nonglycosylated human interleukin-3 compositions

Country Status (4)

Country Link
EP (1) EP0425536A4 (en)
JP (1) JPH04500508A (en)
AU (1) AU3864089A (en)
WO (1) WO1990001039A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU630207B2 (en) * 1989-06-30 1992-10-22 Immunex Corporation Nonglycosylated human interleukin-3 analog proteins
AU690088B2 (en) * 1992-11-24 1998-04-23 G.D. Searle & Co. Interleukin-3 (IL-3) multiple mutation polypeptides

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL96477A0 (en) * 1989-12-01 1991-08-16 Amgen Inc Megakaryocyte production
ES2118756T5 (en) * 1990-08-29 2004-01-16 Genetics Institute, Llc HEMATOPOYESIS STIMULATORS OF MULTIPLE DOMAINS.
CA2069746A1 (en) * 1990-09-28 1992-03-29 Jonathan I. Rosen Hybrid growth factors
US6413509B1 (en) 1992-11-24 2002-07-02 S. Christopher Bauer Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors
US5772992A (en) * 1992-11-24 1998-06-30 G.D. Searle & Co. Compositions for co-administration of interleukin-3 mutants and other cytokines and hematopoietic factors
US5738849A (en) * 1992-11-24 1998-04-14 G. D. Searle & Co. Interleukin-3 (IL-3) variant fusion proteins, their recombinant production, and therapeutic compositions comprising them
US6057133A (en) * 1992-11-24 2000-05-02 G. D. Searle Multivariant human IL-3 fusion proteins and their recombinant production
US6361977B1 (en) 1992-11-24 2002-03-26 S. Christopher Bauer Methods of using multivariant IL-3 hematopoiesis fusion protein
US7091319B1 (en) 1992-11-24 2006-08-15 Bauer S Christopher IL-3 variant hematopoiesis fusion protein
US6153183A (en) * 1992-11-24 2000-11-28 G. D. Searle & Company Co-administration of interleukin-3 mutant polypeptides with CSF's or cytokines for multi-lineage hematopoietic cell production
US6017523A (en) * 1995-06-06 2000-01-25 G.D. Searle & Co. Therapeutic methods employing mutant human interleukin-3 (IL-3) polypeptides
WO2006079169A1 (en) * 2005-01-25 2006-08-03 Apollo Life Sciences Limited Parameter selected gm-csf, il-3, il-4, il-5 and chimeras thereof for therapeutic and diagnostic purposes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60207594A (en) * 1984-03-30 1985-10-19 Ajinomoto Co Inc Production of human interleukin-3
JPS60207595A (en) * 1984-03-30 1985-10-19 Ajinomoto Co Inc Production of human interleukin 3
ES2113338T3 (en) * 1986-12-16 1998-05-01 Gist Brocades Nv MOLECULAR CLONING AND EXPRESSION OF HUMAN IL-3.
OA09736A (en) * 1987-02-18 1993-11-30 Schering Biotech Corp "Human interleukin-3 and muteins thereof".

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU630207B2 (en) * 1989-06-30 1992-10-22 Immunex Corporation Nonglycosylated human interleukin-3 analog proteins
AU690088B2 (en) * 1992-11-24 1998-04-23 G.D. Searle & Co. Interleukin-3 (IL-3) multiple mutation polypeptides

Also Published As

Publication number Publication date
EP0425536A1 (en) 1991-05-08
JPH04500508A (en) 1992-01-30
EP0425536A4 (en) 1992-01-02
WO1990001039A1 (en) 1990-02-08

Similar Documents

Publication Publication Date Title
AU4290789A (en) Oral compositions
AU3481089A (en) Oral compositions
AU3588089A (en) Oral compositions
AU3141589A (en) Anticalculus oral composition
AU4999790A (en) Piperidine compounds and their preparation and use
AU3480889A (en) Oral compositions
AU4148989A (en) Pharmaceutical compositions
GB8904454D0 (en) Oral compositions
AU2397492A (en) Oral suspension formulation
AU3674489A (en) Pharmaceutical compositions
AU3313889A (en) Novel unit dosage form
GB8811829D0 (en) Oral compositions
AU3003789A (en) Anticalculus oral composition
EP0371542A3 (en) Oral composition
AU5970290A (en) Dental composition
AU3946689A (en) Oral compositions
AU3864089A (en) Nonglycosylated human interleukin-3 compositions
AU612525B2 (en) Novel dosage form
AU4447189A (en) Oral compositions
AU2852289A (en) Oral hygiene composition
AU3027389A (en) Compositions
AU612915B2 (en) Thermosetting-resin-forming composition
AU4939690A (en) Anesthetic oral compositions
AU4712089A (en) Spread
AU5351590A (en) Dental preparation